Hypoglycemia
📧 Sign up to get email alerts when something new happens for Hypoglycemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Stimulated Glucagon as a Biomarker of Hypoglycemic Risk in Type 1 Diabetes
This completed clinical trial evaluates stimulated glucagon as a biomarker for hypoglycemic risk in individuals with Type 1 diabetes.
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: "Sexual Activity and Hypoglycemia Risk in Adults With Type 1 or Type 2 Diabetes Using Insulin Therapy and Continuous Glucose Monitoring"
A clinical trial is recruiting to examine sexual activity and hypoglycemia risk in adults with type 1 diabetes mellitus or type 2 diabetes m…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Fasting Induced Hypoglycaemia in Anaesthetised Paediatric Patients
This clinical trial update indicates a study on fasting-induced hypoglycemia in anaesthetised pediatric patients is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: External Carotid Blood Flow in Individuals With Post-Bariatric Hypoglycemia
This clinical trial update indicates that the study on external carotid blood flow in individuals with post-bariatric hypoglycemia is curren…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Frequency of Hypoglycemia in Children With Beta-blocker Treated Long QT-syndrome [NA]
A clinical trial update showing an ongoing, invitation-only study to determine how often hypoglycemia occurs in children with Long QT Syndro…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Differing Levels of Hypoglycemia [EARLY_Phase 1]
An early-phase Phase 1 trial sponsored by the University of Maryland, Baltimore, investigating differing levels of hypoglycemia. The study i…
-
CLINICAL_TRIALS trial_result · 2025-10-22Clinical Trial Update: Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities
Completed clinical trial evaluating continuous glucose monitoring in long-term care facilities for diabetes and hypoglycemia management.
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Role of CGMS Usage in Predicting Risk for Hypoglycemia
A completed clinical trial evaluates whether continuous glucose monitoring usage can predict hypoglycemia risk in individuals with Type 2 di…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric Bypass [NA]
Ongoing clinical trial evaluating an endoscopic gastro-gastrostomy using a large-diameter lumen-apposing metal stent to reverse Roux-en-Y ga…
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Exploration of Continuous Glucose Monitoring on the Intensive Care Unit [NA]
A completed clinical trial update evaluating continuous glucose monitoring in the intensive care unit. The study focused on managing hypogly…
-
EMA approval · 2025-09-17EMA Authorised: Ogluo (Glucagon) — Strongbridge Dublin Limited
EMA has authorised Ogluo, a glucagon medicine from Strongbridge Dublin Limited, for use in diabetes mellitus. The product is approved for em…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients [Phase 1, Phase 2]
A Phase 1/2 pilot trial evaluating high-dose omega-3 fatty acids and vitamin D in adults with type 1 diabetes has completed, with results po…
-
FDA approval · 2025-09-15FDA Approved: GLUCAGON — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s original application for a generic glucagon product, enabling its marketing to treat severe hypoglycemia i…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery [EARLY_Phase 1]
An early-phase (Phase 1) clinical trial evaluating neural and hormonal regulators of insulin secretion after gastric bypass surgery. It is s…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Glucagon and Advanced HCL System to Prevent Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes [NA]
A completed clinical trial evaluated the use of glucagon with an advanced hybrid closed-loop insulin delivery system to prevent exercise-ind…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety, tolerability, and efficacy of E-islet 01 in participants with Type 1 diabetes and impaired…
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: The Construction and Validation of a Risk Prediction Model for Perioperative Hypoglycemia in Digestive Endoscopy
Completed study that develops and validates a risk prediction model for perioperative hypoglycemia in digestive endoscopy.
-
CLINICAL_TRIALS other · 2025-08-14Clinical Trial Update: Islet Transplant for Type 1 or Surgical Diabetes
This clinical trial update concerns islet transplantation for Type 1 Diabetes and related conditions. The study is no longer available.
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Allogeneic Islet Cells Transplanted Onto the Omentum [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating allogeneic pancreatic islet cell transplantation onto the omentum for type 1 diabetes has completed wi…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: GLUCOSAFE 2 - A New Tool for Nutritional Management and Insulin-therapy in the Intensive Care Unit (ICU) [NA]
This clinical trial update reports the completion of GLUCOSAFE 2, a tool for nutritional management and insulin therapy in ICU patients.
-
FDA approval · 2025-07-30FDA Approved: GLUCAGON — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA has approved a supplemental application for glucagon submitted by Fresenius Kabi USA, LLC. The approval finalizes changes proposed i…
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Personalized Hypoglycemia Outpatient Treatment - a Feasibility Study [NA]
The Ottawa Hospital Research Institute is sponsoring a feasibility study on personalized outpatient treatment for hypoglycemia in type 2 dia…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Intermittent Versus Continuous Glucose Monitoring in Intensive Care Unit [NA]
Clinical trial update comparing intermittent versus continuous glucose monitoring in the intensive care unit. The study is currently not yet…
-
FDA approval · 2025-07-25FDA Approved: DEXTROSE — Supplemental Application (Hospira, Inc.)
The FDA approved Hospira's supplemental application for DEXTROSE (dextrose monohydrate), resulting in updated labeling and expanded approval…
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Liver Glycogen and Hypoglycemia in Humans [Phase 1]
Phase 1 clinical trial update examining the relationship between liver glycogen and hypoglycemia in humans.